Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 27, 20 December 2023
Open
Access | Article
Cohort analysis for the present mutation of NPM1 in bone marrow cancer
* Author to whom correspondence should be addressed.
Abstract
DNA is the most important code for deciphering human genetic information. It finally determines proteins through the central dogma. Therefore, gene mutations can cause various diseases. Cancer is one of the most difficult-to-cure diseases caused by mutations. Acute myeloid leukemia is one of the subtypes of bone marrow cancer, this essay will predominantly focus on the study of the mutation gene NPM1 (nucleophosmin 1). In order to understand the differences between the mutated gene NPM1 and other mutated genes, a cohort study analysis of NPM1 is needed. This research helps better understanding of cancer and the variation of NPM1 compared to the others. By researching and analyzing direct clinical data, this essay will contribute to the understanding of cancer and help turn a scientific blank message into a more simple and understandable manner. However, the limitation of this study is insufficient or even missing data. With the development of research and the improvement of data, future studies will be more accurate and effective, providing a more effective reference for exploring targeted therapy of acute myeloid leukemia.
Keywords
Bone marrow cancer, acute myeloid leukemia, mutation gene NPM1
References
1. 10 Oct. 2023 one Marrow Cancer: Symptoms, Treatment, and Outlook Medical News Today Med Lexicon International
2. Thol F Ganser A 2020 Treatment of Relapsed Acute Myeloid Leukemia Curr Treat Options Oncol Jun 29 21 8 66
3. 11 Oct. 2023 Bone Marrow Cancers: What You Need to Know WebMD
4. Ravandi F Stone R Acute Promyelocytic Leukemia: A Perspective. Clin Lymphoma Myeloma Leuk 2017 Sep 17 9 543-544
5. 10 Oct 2023 Key Statistics for Acute Myeloid Leukemia (AML) American Cancer Society
6. 2023 PDQ Adult Treatment Editorial Board. Acute Myeloid Leukemia Treatment (PDQ®): Patient Version
7. 11 Oct 2023 Treatment Response Rates for Acute Myeloid Leukemia (AML) American Cancer Society
8. B J Bain 2017 WHO Classification of Leukemia Reference Module in Life Sciences Elsevier
9. Tabbò F et al 2021 The ALK receptor tyrosine kinase journey: From physiological roles to pathological disruptions In Therap Strat to Overcome ALK Resistance in Cancer pp 1-29
10. 10 Oct 2023 GDC portal.gdc.cancer.gov/analysis?analysisId=2023-09-09T12%3A06%3A 54.333Z&analysisTableTab=result
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 2nd International Conference on Modern Medicine and Global Health
- ISBN (Print)
- 978-1-83558-237-4
- ISBN (Online)
- 978-1-83558-238-1
- Published Date
- 20 December 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/27/20240709
- Copyright
- 20 December 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited